Vitamin C May Help People with Precancerous Blood Disorders
Researchers have found a link between vitamin C and improved survival rates for people with precancerous blood disorders. A study published in the American Cancer Society journal CANCER found that daily vitamin C supplements may help people with precancerous blood conditions and early-stage blood cancers.
The study, called EVITA, involved 109 patients with conditions that can develop into leukemia. Participants were given either a daily dose of 1,000 mg of vitamin C or a placebo. Those who received vitamin C had fewer adverse events and changes in immune signaling molecules that suggested a more favorable outcome.
The researchers found that vitamin C levels returned to normal in participants who took the supplement. This is particularly important for people with conditions that can develop into leukemia, as there is currently no approved treatment to prevent progression.
The study suggests that vitamin C may be a useful tool in cancer treatment, particularly in early intervention. The researchers are continuing to examine the data to better understand the biological processes involved.
The EVITA trial is a significant step forward in understanding the potential benefits of vitamin C in cancer treatment. However, more research is needed to confirm the findings and explore the full potential of vitamin C supplements.
The researchers are hopeful that a larger clinical trial will provide further insights into the use of vitamin C as a treatment for precancerous blood disorders.
